Literature DB >> 3337104

Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism.

E Boerwinkle1, G Utermann.   

Abstract

Human apolipoprotein (apo) E is polymorphic. We have investigated the effect of the apo-E polymorphism on quantitative plasma levels of apo E, apo B, and total cholesterol in a sample of 563 blood-bank donors from Marburg and Giessen, West Germany. The relative frequencies of the epsilon 2, epsilon 3, and epsilon 4 alleles are .063, .793, and .144, respectively. The average effects of the epsilon 2 allele are to raise apo-E levels by 0.95 mg/dl, lower apo B levels by 9.46 mg/dl, and lower total cholesterol levels by 14.2 mg/dl. The average effects of the epsilon 4 allele are to lower apo-E levels by 0.19 mg/dl, to raise apo-B levels by 4.92 mg/dl, and to raise total cholesterol levels by 7.09 mg/dl. The average effects of the epsilon 3 allele are near zero for all three phenotypes. The apo-E polymorphism accounts for 20% of the variability of plasma apo-E levels, 12% of the variability of plasma apo-B levels, and 4% of the variability of total plasma cholesterol levels. The inverse relationship between the genotype-specific average apo-E levels and both the genotype-specific average apo-B and cholesterol levels is offset by a positive relationship between apo-E levels and both apo-B and cholesterol levels within an apo-E genotype. The apo-E polymorphism also has a direct effect on the correlation between apo-E and total cholesterol levels. The implication of these results on multivariate genetic analyses of these phenotypes is discussed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3337104      PMCID: PMC1715322     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  30 in total

1.  Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins.

Authors:  G Utermann; M Jaeschke; J Menzel
Journal:  FEBS Lett       Date:  1975-08-15       Impact factor: 4.124

2.  The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods.

Authors:  E Boerwinkle; R Chakraborty; C F Sing
Journal:  Ann Hum Genet       Date:  1986-05       Impact factor: 1.670

3.  Reciprocal effects of apolipoprotein E alleles (epsilon 2 and epsilon 4) on plasma lipid levels in normolipidemic subjects.

Authors:  M Eto; K Watanabe; K Ishii
Journal:  Clin Genet       Date:  1986-06       Impact factor: 4.438

4.  Bias of the contribution of single-locus effects to the variance of a quantitative trait.

Authors:  E Boerwinkle; C F Sing
Journal:  Am J Hum Genet       Date:  1986-07       Impact factor: 11.025

5.  Isolation and partial characterization of an arginine-rich apolipoprotein from human plasma very-low-density lipoproteins: apolipoprotein E.

Authors:  G Utermann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1975-07

6.  Genetic polymorphism of apolipoprotein E: a variant form of apolipoprotein E2 distinguished by sodium dodecyl sulfate--polyacrylamide gel electrophoresis.

Authors:  G Utermann; K H Weisgraber; W Weber; R W Mahley
Journal:  J Lipid Res       Date:  1984-04       Impact factor: 5.922

7.  Abnormal in vivo metabolism of apolipoprotein E4 in humans.

Authors:  R E Gregg; L A Zech; E J Schaefer; D Stark; D Wilson; H B Brewer
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

8.  The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals.

Authors:  E Boerwinkle; S Visvikis; D Welsh; J Steinmetz; S M Hanash; C F Sing
Journal:  Am J Med Genet       Date:  1987-07

9.  Effects of apoprotein E polymorphism on serum lipoprotein concentration.

Authors:  F W Robertson; A M Cumming
Journal:  Arteriosclerosis       Date:  1985 May-Jun

10.  Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.

Authors:  C Ehnholm; R W Mahley; D A Chappell; K H Weisgraber; E Ludwig; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

View more
  58 in total

1.  Clan genomics and the complex architecture of human disease.

Authors:  James R Lupski; John W Belmont; Eric Boerwinkle; Richard A Gibbs
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

2.  Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol.

Authors:  E Boerwinkle; S A Brown; K Rohrbach; A M Gotto; W Patsch
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

Review 3.  The neuroprotective effects of caffeine in neurodegenerative diseases.

Authors:  Mahshad Kolahdouzan; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2017-04       Impact factor: 5.243

4.  Mining genetic epidemiology data with Bayesian networks application to APOE gene variation and plasma lipid levels.

Authors:  Andrei Rodin; Thomas H Mosley; Andrew G Clark; Charles F Sing; Eric Boerwinkle
Journal:  J Comput Biol       Date:  2005       Impact factor: 1.479

5.  Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism.

Authors:  Jari H Stengård; Andrew G Clark; Kenneth M Weiss; Sharon Kardia; Deborah A Nickerson; Veikko Salomaa; Christian Ehnholm; Eric Boerwinkle; Charles F Sing
Journal:  Am J Hum Genet       Date:  2002-08-05       Impact factor: 11.025

6.  Decreases in plasma A beta 1-40 levels with aging in non-demented elderly with ApoE-epsilon 4 allele.

Authors:  N Pomara; B Shao; T Wisniewski; P D Mehta
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

7.  The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances.

Authors:  S L Reilly; R E Ferrell; B A Kottke; M I Kamboh; C F Sing
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

8.  Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations.

Authors:  E Boerwinkle; S Brown; A R Sharrett; G Heiss; W Patsch
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

9.  An increased incidence of apolipoprotein E2/E2 and E4/E4 in retinitis pigmentosa.

Authors:  L Huq; T McLachlan; H M Hammer; D Bedford; C J Packard; J Shepherd; C A Converse
Journal:  Lipids       Date:  1993-11       Impact factor: 1.880

10.  Genetic and metabolic determinants of plasma PCSK9 levels.

Authors:  Susan G Lakoski; Thomas A Lagace; Jonathan C Cohen; Jay D Horton; Helen H Hobbs
Journal:  J Clin Endocrinol Metab       Date:  2009-04-07       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.